156740-78-2

Basic information

• Product Name: 2,6-dimethyl-4-nitrophenyl trifluoromethanesulphonate
• Synonyms: 2,6-dimethyl-4-nitrophenyl trifluoromethanesulphonate
• CAS NO: 156740-78-2
• Molecular Weight: 299.227
• Mol File: 156740-78-2.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 2,6-dimethyl-4-nitrophenyl trifluoromethanesulphonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-dimethyl-4-nitrophenyl trifluoromethanesulphonate(156740-78-2)
• EPA Substance Registry System: 2,6-dimethyl-4-nitrophenyl trifluoromethanesulphonate(156740-78-2)

Safety Data

• Hazardous Substances Data: 156740-78-2(Hazardous Substances Data)

Upstream product

• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 2423-71-4 2,6-dimethyl-4-nitro phenol 
• 1025373-45-8 trifluoromethanesulfonic acid anhydride 
• 358-23-6 trifluoromethylsulfonic anhydride 

Downstream Products

• 53906-84-6 2-bromo-1,3-dimethyl-5-nitrobenzene 
• 1425187-94-5 2,6-dimethyl-4-nitrophenyl(phenyl)sulfoxide 
• 1425187-95-6 2,6-dimethyl-4-nitrophenyl(4'-nitrophenyl)sulfoxide 
• 114660-00-3 2,6-dimethyl-4-nitrophenyl (phenyl) sulfide 
• 1425187-97-8 2,6-dimethyl-4-nitrophenyl (4'-nitrophenyl) sulfide 
• 1736-85-2 2-fluoro-1,3-dimethyl-5-nitrobenzene 
• 1425188-03-9 C₈H₈⁽¹⁸⁾FNO₂ 
• 1393125-91-1 1-(2,6-dimethyl-4-nitrophenyl)-4-(trifluoromethyl)-1H-imidazole 

Relevant articles and documents

New 4,4'-Bis(9-carbazolyl)-biphenyl derivatives with locked carbazole-biphenyl junctions: High-triplet state energy materials

We synthesized a series of 4,4'-bis(9-carbazolyl)-biphenyl (CBP) derivatives, using methyl groups as spatially demanding groups, locking the angle between the carbazole subunit and the biphenyl backbone as potential matrix material for blue organic light-

Glucagon Receptor Modulators

The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, A1, A2, A3, A4, L, B1, B2, B3 and B4 are as defined herein. The compounds of Formula I have been found to act as glucagon antagonists or inverse agonists. Consequently, the compounds of Formula I and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucagon.

3-(4-BENZYLOXYPHENYL)PROPANOIC ACID DERIVATIVES

The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, which can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. They unexpectedly show superior GPR40 receptor agonist activity, and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor related diseases in mammals.